Factor | Level | Unadjusted HR (95% c.i.) | Adjusted HR (95% c.i.) | Adjusted P-value |
---|---|---|---|---|
Sex | Male | 1 (ref. level) | 1 (ref. level) | 0.002 |
Female | 0.73 (0.52; 1.02) | 0.59 (0.44; 0.80) | ||
Study Arm | Facility | 1 (ref. level) | 1 (ref. level) | |
Home-based | 1.003 (0.77; 1.31) | 0.92 (0.70; 1.20) | 0.56 | |
Age | Per 10 year increase | 1.002 (0.84; 1.20) | 1.09 (0.91; 1.31) | 0.30 |
WHO stage | I | 0.58 (0.08; 4.0) | 0.72 (0.12; 4.42) | 0.009 |
II | 1 (ref. level) | 1 (ref. level) | ||
III | 1.99 (1.57; 2.53) | 1.41 (1.09; 1.83) | ||
IV | 3.64 (2.53; 5.23) | 2.23 (1.45; 3.43) | ||
√ CD4/25 | Per transformed CD4 increase * | 0.52 (0.44; 0.61) | 0.61 (0.51; 0.73) | < 0.001 |
Log10 plasma viral load | Per 1 log increase | 1.15 (1.004; 1.31) | 1.04 (0.91; 1.18) | 0.51 |
Weight | Per 5 kg increase | 0.74 (0.67; 0.82) | 0.77 (0.70; 0.85) | < 0.001 |
Haemoglobin | Per 2 g/dl increase | 0.82 (0.72; 0.93) | 0.93 (0.81; 1.07) | 0.35 |
Cotrimoxazole prophylaxis | Yes No | 1 (ref. level) 2.03 (1.08; 3.81) | 1 (ref. level) 2.18 (1.10; 4.34) | 0.02 |